Reduced Cell-Free Mitochondrial DNA Levels Were Induced by Antipsychotics Treatment in First-Episode Patients With Schizophrenia

Cell-free mitochondrial DNA (cf-mtDNA) is a damage-associated molecular pattern that boosts the release of cytokines and induces the immune response of the body; therefore, it is closely related to mental diseases. This study aims to evaluate a potential link between cf-mtDNA and clinical progressio...

Full description

Bibliographic Details
Main Authors: Houxian Ouyang, Minfang Huang, Yongming Xu, Qin Yao, Xiangping Wu, Dongsheng Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2021.652314/full
_version_ 1818846662839238656
author Houxian Ouyang
Houxian Ouyang
Minfang Huang
Minfang Huang
Yongming Xu
Qin Yao
Qin Yao
Xiangping Wu
Dongsheng Zhou
Dongsheng Zhou
author_facet Houxian Ouyang
Houxian Ouyang
Minfang Huang
Minfang Huang
Yongming Xu
Qin Yao
Qin Yao
Xiangping Wu
Dongsheng Zhou
Dongsheng Zhou
author_sort Houxian Ouyang
collection DOAJ
description Cell-free mitochondrial DNA (cf-mtDNA) is a damage-associated molecular pattern that boosts the release of cytokines and induces the immune response of the body; therefore, it is closely related to mental diseases. This study aims to evaluate a potential link between cf-mtDNA and clinical progression in first-episode patients with schizophrenia. In this study, plasma cf-mtDNA levels in 34 first-episode patients with schizophrenia before and after 8 weeks of antipsychotic treatment were examined. In addition, the clinical progression of first-episode schizophrenia was assessed using the Positive and Negative Syndrome Scale (PANSS). The copy number changes in the plasma cf-mtDNA (Δcf-mtDNA) were significantly correlated with changes in the PANSS scale scores (ΔPANSS) in first-episode patients with schizophrenia (ΔPANSS total score, P = 0.002; ΔPANSS positive score, P = 0.01). Plasma cf-mtDNA may represent a relevant tool in the future to assist in the assessment of clinical progression in first-episode patients with schizophrenia.
first_indexed 2024-12-19T05:49:07Z
format Article
id doaj.art-559e45b05c434c54bcf43ecc5691ca46
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-12-19T05:49:07Z
publishDate 2021-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-559e45b05c434c54bcf43ecc5691ca462022-12-21T20:33:42ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402021-07-011210.3389/fpsyt.2021.652314652314Reduced Cell-Free Mitochondrial DNA Levels Were Induced by Antipsychotics Treatment in First-Episode Patients With SchizophreniaHouxian Ouyang0Houxian Ouyang1Minfang Huang2Minfang Huang3Yongming Xu4Qin Yao5Qin Yao6Xiangping Wu7Dongsheng Zhou8Dongsheng Zhou9Department of Psychiatry, Ningbo Kangning Hospital, Ningbo, ChinaDepartment of Laboratory Diagnostics, Ningbo Kangning Hospital, Ningbo, ChinaDepartment of Psychiatry, Ningbo Kangning Hospital, Ningbo, ChinaDepartment of Pharmacology, Ningbo Kangning Hospital, Ningbo, ChinaDepartment of Psychiatry, Ningbo Kangning Hospital, Ningbo, ChinaDepartment of Psychiatry, Ningbo Kangning Hospital, Ningbo, ChinaNingbo Key Laboratory of Sleep Medicine, Ningbo, ChinaDepartment of Psychiatry, Ningbo Kangning Hospital, Ningbo, ChinaDepartment of Psychiatry, Ningbo Kangning Hospital, Ningbo, ChinaNingbo Key Laboratory of Sleep Medicine, Ningbo, ChinaCell-free mitochondrial DNA (cf-mtDNA) is a damage-associated molecular pattern that boosts the release of cytokines and induces the immune response of the body; therefore, it is closely related to mental diseases. This study aims to evaluate a potential link between cf-mtDNA and clinical progression in first-episode patients with schizophrenia. In this study, plasma cf-mtDNA levels in 34 first-episode patients with schizophrenia before and after 8 weeks of antipsychotic treatment were examined. In addition, the clinical progression of first-episode schizophrenia was assessed using the Positive and Negative Syndrome Scale (PANSS). The copy number changes in the plasma cf-mtDNA (Δcf-mtDNA) were significantly correlated with changes in the PANSS scale scores (ΔPANSS) in first-episode patients with schizophrenia (ΔPANSS total score, P = 0.002; ΔPANSS positive score, P = 0.01). Plasma cf-mtDNA may represent a relevant tool in the future to assist in the assessment of clinical progression in first-episode patients with schizophrenia.https://www.frontiersin.org/articles/10.3389/fpsyt.2021.652314/fullfirst-episode schizophreniacell-free mitochondrial DNApositive and negative syndrome scaleclinical progressionantipsychotics
spellingShingle Houxian Ouyang
Houxian Ouyang
Minfang Huang
Minfang Huang
Yongming Xu
Qin Yao
Qin Yao
Xiangping Wu
Dongsheng Zhou
Dongsheng Zhou
Reduced Cell-Free Mitochondrial DNA Levels Were Induced by Antipsychotics Treatment in First-Episode Patients With Schizophrenia
Frontiers in Psychiatry
first-episode schizophrenia
cell-free mitochondrial DNA
positive and negative syndrome scale
clinical progression
antipsychotics
title Reduced Cell-Free Mitochondrial DNA Levels Were Induced by Antipsychotics Treatment in First-Episode Patients With Schizophrenia
title_full Reduced Cell-Free Mitochondrial DNA Levels Were Induced by Antipsychotics Treatment in First-Episode Patients With Schizophrenia
title_fullStr Reduced Cell-Free Mitochondrial DNA Levels Were Induced by Antipsychotics Treatment in First-Episode Patients With Schizophrenia
title_full_unstemmed Reduced Cell-Free Mitochondrial DNA Levels Were Induced by Antipsychotics Treatment in First-Episode Patients With Schizophrenia
title_short Reduced Cell-Free Mitochondrial DNA Levels Were Induced by Antipsychotics Treatment in First-Episode Patients With Schizophrenia
title_sort reduced cell free mitochondrial dna levels were induced by antipsychotics treatment in first episode patients with schizophrenia
topic first-episode schizophrenia
cell-free mitochondrial DNA
positive and negative syndrome scale
clinical progression
antipsychotics
url https://www.frontiersin.org/articles/10.3389/fpsyt.2021.652314/full
work_keys_str_mv AT houxianouyang reducedcellfreemitochondrialdnalevelswereinducedbyantipsychoticstreatmentinfirstepisodepatientswithschizophrenia
AT houxianouyang reducedcellfreemitochondrialdnalevelswereinducedbyantipsychoticstreatmentinfirstepisodepatientswithschizophrenia
AT minfanghuang reducedcellfreemitochondrialdnalevelswereinducedbyantipsychoticstreatmentinfirstepisodepatientswithschizophrenia
AT minfanghuang reducedcellfreemitochondrialdnalevelswereinducedbyantipsychoticstreatmentinfirstepisodepatientswithschizophrenia
AT yongmingxu reducedcellfreemitochondrialdnalevelswereinducedbyantipsychoticstreatmentinfirstepisodepatientswithschizophrenia
AT qinyao reducedcellfreemitochondrialdnalevelswereinducedbyantipsychoticstreatmentinfirstepisodepatientswithschizophrenia
AT qinyao reducedcellfreemitochondrialdnalevelswereinducedbyantipsychoticstreatmentinfirstepisodepatientswithschizophrenia
AT xiangpingwu reducedcellfreemitochondrialdnalevelswereinducedbyantipsychoticstreatmentinfirstepisodepatientswithschizophrenia
AT dongshengzhou reducedcellfreemitochondrialdnalevelswereinducedbyantipsychoticstreatmentinfirstepisodepatientswithschizophrenia
AT dongshengzhou reducedcellfreemitochondrialdnalevelswereinducedbyantipsychoticstreatmentinfirstepisodepatientswithschizophrenia